Insider · CIK 0001778843

Wallace Owen B.

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001778843

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-01-02	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+119K sh	—	—	119,000
2023-01-03	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+135K sh	—	—	135,000
2022-03-01	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+117K sh	—	—	117,450
2021-06-23	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+113K sh	—	—	113,298
2021-04-12	GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+387K sh	—	—	387,069
2020-09-14	FULCFulcrum Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+6,350 sh	$7.84	+$49.8K	133,438
2020-09-14	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−6,350 sh	—	—	75,592
2020-07-08	FULCFulcrum Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,951 sh	$7.84	+$23.1K	130,039
2020-07-08	FULCFulcrum Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,951 sh	$20.00	−$59K	127,088
2020-07-08	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,951 sh	—	—	81,942
2020-06-30	FULCFulcrum Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+141 sh	$7.84	+$1,105.44	127,229
2020-06-30	FULCFulcrum Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−141 sh	$20.00	−$2,820	127,088
2020-06-30	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−141 sh	—	—	84,893
2020-05-28	FULCFulcrum Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,232 sh	$7.84	+$17.5K	129,320
2020-05-28	FULCFulcrum Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−2,232 sh	$20.00	−$44.6K	127,088
2020-05-28	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,232 sh	—	—	85,034
2020-05-27	FULCFulcrum Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+448 sh	$7.84	+$3,512.32	127,536
2020-05-27	FULCFulcrum Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−448 sh	$20.00	−$8,960	127,088
2020-05-27	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−448 sh	—	—	87,266
2020-05-26	FULCFulcrum Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+412 sh	$7.84	+$3,230.08	127,500
2020-05-26	FULCFulcrum Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−412 sh	$20.00	−$8,240	127,088
2020-05-26	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−412 sh	—	—	87,714
2020-02-19	FULCFulcrum Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+6,088 sh	$7.84	+$47.7K	133,176
2020-02-19	FULCFulcrum Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−6,088 sh	$20.00	−$122K	127,088
2020-02-19	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−6,088 sh	—	—	88,126
2020-01-23	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+58.9K sh	—	—	58,900
2019-07-18	FULCFulcrum Therapeutics, Inc. · Stock Option (right to buy)A Award	Chief Scientific Officer	AAward	+44.5K sh	—	—	44,493

Recent filings

Accepted (ET)
Jan 44
Wallace Owen B.0001209191-24-000768
SEC(opens sec.gov)
Jan 44
Wallace Owen B.0001209191-23-000958
SEC(opens sec.gov)
Mar 24
Wallace Owen B.0000899243-22-008681
SEC(opens sec.gov)
Jun 254
Wallace Owen B.0000899243-21-025984
SEC(opens sec.gov)
Sep 144
Wallace Owen B.0000899243-20-024982
SEC(opens sec.gov)
Jul 94
Wallace Owen B.0000899243-20-018817
SEC(opens sec.gov)
Jul 14
Wallace Owen B.0000899243-20-018121
SEC(opens sec.gov)
Jun 14
Wallace Owen B.0000899243-20-014719
SEC(opens sec.gov)
May 294
Wallace Owen B.0000899243-20-014552
SEC(opens sec.gov)
May 284
Wallace Owen B.0000899243-20-014416
SEC(opens sec.gov)

Companies

Address

C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET

CAMBRIDGE, MA, 02139